Abstract:
A therapeutic mobilization device includes a flexion assembly, a pro/supination assembly and a valgus carrying angle compensation device. The flexion assembly has an arm attachment assembly and an elbow actuator and the elbow actuator defines and axes of rotation. The pro/supination assembly is attached to flexion assembly and has a distal forearm attachment assembly and a pro/supination actuator operably connected thereto. The valgus carrying angle compensation device is operably attached to the flexion assembly and the pro/supination assembly. Preferably the pro/supination assembly is slidably mounted on a housing shaft whereby during flexion the pro/supination assembly is free to move along the housing shaft. Further, preferably the arm attachment assembly includes an attachment ring and an adjustable clamp pivotally attached thereto whereby the attachment ring defines a pro/supination axis and the adjustable clamp pivots orthogonally to the pro/supination axis.
Abstract:
The present invention includes methods of treating acute myocardial infarction in a subject, comprising administering to the subject a therapeutically effective amount of a non-proteolytically activated thrombin receptor agonist.
Abstract:
Endothelial dysfunction (ED) is associated with a number of diseases and disorders. Agonists of the non-proteolytically activated thrombin receptor can be used in methods to treat ED or ED-related diseases and disorders.
Abstract:
Endothelial dysfunction (ED) is associated with a number of diseases and disorders. Agonists of the non-proteolytically activated thrombin receptor can be used in methods to treat ED or ED-related diseases and disorders.
Abstract:
Disclosed are antibodies and antigen-binding fragments that bind to a complementary peptide having an amino acid sequence that is encoded by the complement of a nucleotide sequence encoding thrombin or a portion thereof. Such antibodies and antigen-binding fragments can be agonists or antagonists of thrombin receptor-mediated events. Also disclosed are methods of using the agonist antibodies and antigen-binding fragments of the invention to activate the non-proteolytically activated thrombin receptor (NPAR) in a subject in need of such treatment. In addition, methods of using the antagonist antibodies and antigen-binding fragments of the invention to inhibit activation of the NPAR in a subj ect in need of such treatment are disclosed.
Abstract:
A control system is adapted for use in association with a therapeutic motion and splinting device. The therapeutic device has at least one component that is monitored. The system comprises the steps of defining the range of motion, defining the maximum reverse on load, monitoring the reverse on load and moving the device through its range of motion. A first and second maximum limit of range of motion in a first and second direction are respectively defined. A maximum reverse on load is defined and is monitored whereby the deformation of the at least one component is monitored and the load created is interpreted. The device is cycled between a first and second position defined by one of the first maximum limit and the maximum reverse on load and one of the second maximum limit and the maximum reverse on load respectively.
Abstract in simplified Chinese:本发明是有关于促进心脏组织修补之方法,包括将一治疗有效量之血管生成的凝血衍生的胜,给药至心脏组织,及/或有关于抑制或减少血管栓塞或再狭窄之方法。本发明也有关于刺激再血管化之方法。在另一具体实施例中,本发明也有关于使用凝血衍生的胜,以制造用于本发明所说明的方法之药剂。
Abstract:
A control system is adapted for use in association with a therapeutic motion and splinting device. The therapeutic device has at least one component that is monitored. The system comprises the steps of defining the range of motion, defining the maximum reverse on load, monitoring the reverse on load and moving the device through its range of motion. A first and second maximum limit of range of motion in a first and second direction are respectively defined. A maximum reverse on load is defined and is monitored whereby the deformation of the at least one component is monitored and the load created is interpreted. The device is cycled between a first and second position defined by one of the first maximum limit and the maximum reverse on load and one of the second maximum limit and the maximum reverse on load respectively.